Posts by Matt Ozga
January 6, 2024: In-Person Meet & Greet in Leicester, Mass.
Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event in Leicester, Massachusetts on Saturday, January 6, starting at 10:30 a.m. ET.…
Read MoreAFTD Webinar: Approaching a Cure — FTD Genetics and Clinical Trials
The landscape of FTD research has evolved tremendously over the last decade. FTD-causing genetic variants, and the mechanisms they disturb, offer a window to developing disease-modifying medications that target those…
Read MoreAFTD Receives $600,000 Gift for Vital Research and Family Support
Today, AFTD announced that it has received a $600,000 gift from the Open Hand Foundation, which is committed to finding a cure for FTD. Received on Wednesday, November 29th, this…
Read MoreOpen Hand Foundation Provides AFTD $600K for FTD Research
AFTD is pleased to announce that we have received a gift of $600,000 from the Open Hand Foundation to further its mission to hasten a cure for FTD and improve…
Read MoreDecember 16: In-Person Meet & Greet in Boulder, CO
Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event in Boulder, Colorado on December 16, starting at 2 p.m. MT. Download…
Read MorePerspectives in FTD Research Webinar: Why PSP and CBS Clinical Trials Matter
Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are FTD disorders that primarily affect movement and are sometimes called atypical parkinsonism. In this Perspectives in FTD Research Webinar, presented jointly…
Read MoreFDA Clears Way for Clinical Trial for AviadoBio Therapy That Could Halt FTD Progression
AviadoBio will soon open U.S. clinical trial sites for an experimental gene therapy that could halt the progression of FTD when caused by a variant in the GRN gene, the…
Read MoreNovember 13, 2023 — Penn FTD Center Annual Caregiver Conference
The Penn FTD Center’s Annual Caregiver Conference is for those diagnosed with FTD, and their caregivers, family, and friends to access information and support. With presentations from leading experts in…
Read MoreAFTD Webinar: Grief, Loss, and Hope — Helping Families Living with FTD
FTD is the most common dementia for people under 60, and often occurs when there are teens or young adults still at home. An FTD diagnosis can bring feelings of…
Read MoreAviadoBio Begins Clinical Trial to Evaluate AVB-101 for Treatment of FTD
Today, AviadoBio announced the start of its Phase 1/2 clinical trial to evaluate AVB-101 as a one-time treatment for candidates who have the progranulin (GRN) genetic variant. AFTD applauds AviadoBio’s…
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)